Shandong Wohua Pharmaceutical Co., Ltd.
Simbol: 002107.SZ
SHZ
4.82
CNYPrețul de piață astăzi
64.7237
Raportul P/E
-0.2255
Raportul PEG
2.78B
MRK Cap
- 0.00%
Randament DIV
Shandong Wohua Pharmaceutical Co., Ltd. (002107-SZ) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1553.9 | 401.1 | 278.3 | 326.8 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 489.91 | 120.5 | 165.9 | 120.6 | |||||||||||||||||||||
balance-sheet.row.inventory | 580.07 | 149.1 | 146 | 165.9 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 31.94 | 2.3 | 9 | 7.2 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 2655.83 | 673 | 599.2 | 620.6 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1542.42 | 383.2 | 409.8 | 447.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 130.03 | 32.5 | 32.5 | 32.5 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 144.07 | 36.8 | 36 | 54.8 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 274.1 | 69.4 | 68.5 | 87.3 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 73.91 | 18.4 | 19.1 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 2.8 | 0.7 | 1.2 | 2.8 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 6.43 | 0 | 2.2 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1899.66 | 471.7 | 500.8 | 540.5 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 4555.49 | 1144.7 | 1100 | 1161.1 | |||||||||||||||||||||
balance-sheet.row.account-payables | 223.67 | 52.9 | 45.3 | 26.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 4.7 | 2.7 | 1 | 2.8 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 39.43 | 3.1 | 31.3 | 20.9 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | -17.39 | -17.9 | 0.4 | 0.1 | |||||||||||||||||||||
Deferred Revenue Non Current | 72.77 | 17.9 | 20.7 | 23.8 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17.38 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 762.54 | 226.7 | 224.7 | 168.5 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 75.16 | 5.3 | 26.8 | 28.1 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1.01 | 0.4 | 0.4 | 0 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1209.2 | 293.3 | 310.2 | 231.8 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 2308.84 | 577.2 | 577.2 | 577.2 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 731.37 | 183.8 | 129.7 | 183.7 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 167.6 | 44.2 | 39.6 | 59.8 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3207.81 | 805.3 | 746.5 | 820.7 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4555.49 | 1144.7 | 1100 | 1161.1 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 120.56 | 28.2 | 43.3 | 108.5 | |||||||||||||||||||||
balance-sheet.row.total-equity | 3328.36 | 833.5 | 789.8 | 929.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4555.49 | - | - | - | |||||||||||||||||||||
Total Investments | 73.91 | 18.4 | 19.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-debt | 4.74 | 2.7 | 1.4 | 2.8 | |||||||||||||||||||||
balance-sheet.row.net-debt | -1549.16 | -398.4 | -276.9 | -324 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 42.99 | 58.8 | 89.9 | 161.3 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | -0.12 | 33.2 | 35.3 | 33 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0.7 | 2.2 | 1.3 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -18.9 | -2.2 | -1.3 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | 44.96 | 47.6 | 54.9 | -14 | |||||||||||||||||||||
cash-flows.row.account-receivables | 50.32 | 50.3 | -40.8 | 63.3 | |||||||||||||||||||||
cash-flows.row.inventory | -5.36 | -5.4 | 15.5 | -53.8 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 2.6 | 78.1 | -24.8 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 2.2 | 1.3 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 64.7 | 7.8 | 5.1 | 19.8 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 152.53 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -2.21 | -2.7 | -6.8 | -19.1 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.06 | 0.1 | 1.2 | 0 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 0.06 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2.15 | -2.6 | -5.6 | -19.1 | |||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.3 | -188.8 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -150.1 | -154.9 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | -3.55 | -3.6 | -79 | -188.8 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.55 | -3.6 | -229.3 | -343.7 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 147.9 | 122.8 | -49.7 | -162.6 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1551.56 | 401.1 | 276.5 | 326.2 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1403.67 | 278.3 | 326.2 | 488.9 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 152.53 | 129.2 | 185.3 | 200.1 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -2.21 | -2.7 | -6.8 | -19.1 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 150.32 | 126.5 | 178.5 | 181 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 882.86 | 894.3 | 1014.8 | 942.7 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 235.14 | 241.4 | 250.9 | 212.4 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 647.73 | 652.9 | 763.9 | 730.3 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 37.89 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 19.49 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 491.95 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0.2 | -2.3 | 63 | 41.9 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 613.64 | 606.5 | 651.5 | 523.4 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 848.78 | 848 | 902.4 | 735.7 | |||||||||||||||||||||
income-statement-row.row.interest-income | 4.85 | 5.2 | 4.7 | 6.8 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 4.7 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 491.95 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 5.22 | 8.3 | -1.5 | -2.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.2 | -2.3 | 63 | 41.9 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 5.22 | 8.3 | -1.5 | -2.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 4.7 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 18.56 | 33.2 | 38.5 | 50.1 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 48.25 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 34.94 | 46.3 | 112.3 | 192.7 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 40.17 | 54.6 | 110.8 | 190 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7.01 | 8 | 20.9 | 28.6 | |||||||||||||||||||||
income-statement-row.row.net-income | 42.99 | 58.8 | 107.4 | 163.4 |
Întrebări frecvente
Ce este Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) totalul activelor?
Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) activele totale sunt 1144706388.000.
Care este venitul anual al întreprinderii?
Venitul anual este 401753358.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.734.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este 0.260.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.049.
Care este venitul total al întreprinderii?
Venitul total este 0.040.
Care este Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) profitul net (venitul net)?
Profitul net (venitul net) este 58767086.000.
Care este datoria totală a firmei?
Datoria totală este 2727141.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 606549582.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 456686925.000.